Cargando…

Adverse Renal Effects of Anticancer Immunotherapy: A Review

SIMPLE SUMMARY: The immune system has a natural ability to work against cancer cells; however, in many cases this ability is insufficient, and cancers develop methods enabling them to escape from the supervision of immune cells. Novel therapeutic methods used in neoplastic diseases are based on enco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Borówka, Maciej, Łącki-Zynzeling, Stanisław, Nicze, Michał, Kozak, Sylwia, Chudek, Jerzy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454552/ https://www.ncbi.nlm.nih.gov/pubmed/36077623 http://dx.doi.org/10.3390/cancers14174086

Ejemplares similares

A study indicates an essential link between a mild deterioration in excretory kidney function and the risk of neutropenia during cancer chemotherapy
por: Stryczyńska-Mirocha, Adriana, et al.
Publicado: (2023)

Low symptomatic COVID-19 in an elderly patient with follicular lymphoma treated with rituximab-based immunotherapy: A case report
por: Łącki, Stanisław, et al.
Publicado: (2021)

Infectious complications during immunochemotherapy of post-transplantation lymphoproliferative disease–can we decrease the risk? Two case reports and review of literature
por: Gładyś, Aleksandra, et al.
Publicado: (2021)

Immune-related adverse events during anticancer immunotherapy: Pathogenesis and management
por: Stucci, Stefania, et al.
Publicado: (2017)

Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies
por: Chen, Chun-Bing, et al.
Publicado: (2018)

Anticancer Drugs Induced Severe Adverse Cutaneous Drug Reactions: An Updated Review on the Risks Associated with Anticancer Targeted Therapy or Immunotherapies
por: Ng, Chau Yee, et al.
Publicado: (2018)

Systemic Interleukins’ Profile in Early and Advanced Colorectal Cancer
por: Czajka-Francuz, Paulina, et al.
Publicado: (2021)

The role of osteoprotegerin in the development, progression and management of abdominal aortic aneurysms
por: Migacz, Maciej, et al.
Publicado: (2020)

Pre-procedural renal resistive index accurately predicts contrast-induced acute kidney injury in patients with preserved renal function submitted to coronary angiography
por: Wybraniec, Maciej T., et al.
Publicado: (2016)

Alphaviruses in Immunotherapy and Anticancer Therapy
por: Lundstrom, Kenneth
Publicado: (2022)

Classification of current anticancer immunotherapies
por: Galluzzi, Lorenzo, et al.
Publicado: (2014)

Comprehensive Review on Betulin as a Potent Anticancer Agent
por: Król, Sylwia Katarzyna, et al.
Publicado: (2015)

Transplanted kidney loss during colorectal cancer chemotherapy: A case report
por: Pośpiech, Marta, et al.
Publicado: (2022)

Atorvastatin facilitates protection against contrast-induced nephropathy in patients undergoing coronary angiography via humoral mediators rather than altered renal hemodynamics
por: Wybraniec, Maciej T., et al.
Publicado: (2018)

Renal resistive index and long-term outcome in patients with coronary artery disease
por: Wybraniec, Maciej T., et al.
Publicado: (2020)

Unleashing the power of NK cells in anticancer immunotherapy
por: Vogler, Meike, et al.
Publicado: (2021)

Renal Tubular Acidosis an Adverse Effect of PD-1 Inhibitor Immunotherapy
por: El Bitar, Sandy, et al.
Publicado: (2018)

Comparison of Anticancer Drug Toxicities: Paradigm Shift in Adverse Effect Profile
por: Basak, Debasish, et al.
Publicado: (2021)

Trial Watch: Adoptive cell transfer for anticancer immunotherapy
por: Aranda, Fernando, et al.
Publicado: (2014)

Trial Watch: Adoptive cell transfer for anticancer immunotherapy
por: Vacchelli, Erika, et al.
Publicado: (2013)

Enhancing anticancer activity of checkpoint immunotherapy by targeting RAS
por: Ward, Antonio B., et al.
Publicado: (2020)

Safety and adverse reactions in subcutaneous allergen immunotherapy: a review
por: Incorvaia, Cristoforo, et al.
Publicado: (2023)

Gastrointestinal adverse events of immunotherapy
por: Cappello, Giovanni, et al.
Publicado: (2021)

Memory NK Cell Features Exploitable in Anticancer Immunotherapy
por: Capuano, Cristina, et al.
Publicado: (2019)

Regulatory T Cells in Tumor Microenvironment and Approach for Anticancer Immunotherapy
por: Kim, Jung-Ho, et al.
Publicado: (2020)

Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy
por: Wu, Yuze, et al.
Publicado: (2022)

Cardiotoxicity of Contemporary Anticancer Immunotherapy
por: Dal’bo, Natalie, et al.
Publicado: (2020)

Melatonin Anticancer Effects: Review
por: Di Bella, Giuseppe, et al.
Publicado: (2013)

Adverse Events of Oncologic Immunotherapy and Their Management
por: Barber, Fedricker Diane
Publicado: (2019)

Locoregional Lymphatic Delivery Systems Using Nanoparticles and Hydrogels for Anticancer Immunotherapy
por: Cho, Kyeong Jin, et al.
Publicado: (2022)

Enhancing the Anticancer Efficacy of Immunotherapy through Combination with Histone Modification Inhibitors
por: Sun, Wanyu, et al.
Publicado: (2018)

Systemic adverse effects and toxicities associated with immunotherapy: A review
por: Kichloo, Asim, et al.
Publicado: (2021)

Differential renal adverse effects of ibuprofen and indomethacin in preterm infants: a review
por: Pacifici, Gian Maria
Publicado: (2014)

Primary Hyperparathyroidism in Patients with Multiple Endocrine Neoplasia Type 1
por: Piecha, Grzegorz, et al.
Publicado: (2010)

Benefitial role of electrochemotherapy in locally advanced pancreatic cancer – radiological perspective
por: Kozak, Oliwia, et al.
Publicado: (2022)

Assessment of renal function in geriatric palliative care patients – comparison of creatinine-based estimation equations
por: Deskur-Smielecka, Ewa, et al.
Publicado: (2017)

Emerging Management Approach for the Adverse Events of Immunotherapy of Cancer
por: Rahman, Md. Mominur, et al.
Publicado: (2022)

Cutaneous Adverse Reactions of Immunotherapy in Patients with Advanced Melanoma
por: Nikolaou, Vasiliki, et al.
Publicado: (2023)

The Potential Anticancer Activity of Phytoconstituents against Gastric Cancer—A Review on In Vitro, In Vivo, and Clinical Studies
por: Nakonieczna, Sylwia, et al.
Publicado: (2020)

Epi-drugs in combination with immunotherapy: a new avenue to improve anticancer efficacy
por: Mazzone, Roberta, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_mkp71i8ps8dm8k54fsfqail13a